Alimera Sciences | ALIM - Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 9.39B 4.16B 2026-03
Bayer EUR 6.67B 774M 2025-12
Insmed USD 582.19M 71.74M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06